Literature DB >> 26281029

Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation.

G Battipaglia1,2, A Ruggeri1, E Brissot1, A-C Mamez1, F Malard1, R Belhocine1, A Vekhoff1, F Giannotti1, T Ledraa1, M Labopin1,3, M-T Rubio1,4, M Mohty1,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26281029     DOI： 10.1038/bmt.2015.182

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration.

Authors:  J Trotman; I Nivison-Smith; A Dodds
Journal:  Bone Marrow Transplant       Date:  1999-04       Impact factor: 5.483

2.  Risk factors for severe hemorrhagic cystitis following BMT.

Authors:  A Seber; X O Shu; T Defor; S Sencer; N Ramsay
Journal:  Bone Marrow Transplant       Date:  1999-01       Impact factor: 5.483

3.  Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.

Authors:  Hirohisa Nakamae; Barry Storer; Brenda M Sandmaier; David G Maloney; Chris Davis; Lawrence Corey; Rainer Storb; Michael Boeckh
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

4.  Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.

Authors:  M Fanucchi; J Glaspy; J Crawford; J Garst; R Figlin; W Sheridan; D Menchaca; D Tomita; H Ozer; L Harker
Journal:  N Engl J Med       Date:  1997-02-06       Impact factor: 91.245

5.  Secondary failure of platelet recovery after hematopoietic stem cell transplantation.

Authors:  B Bruno; T Gooley; K M Sullivan; C Davis; W I Bensinger; R Storb; R A Nash
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

6.  Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.

Authors:  A Dominietto; A M Raiola; M T van Lint; T Lamparelli; F Gualandi; G Berisso; S Bregante; F Frassoni; L Casarino; S Verdiani; A Bacigalupo
Journal:  Br J Haematol       Date:  2001-01       Impact factor: 6.998

7.  The problem of thrombocytopenia after hematopoietic stem cell transplantation.

Authors:  R A Nash; T Gooley; C Davis; F R Appelbaum
Journal:  Stem Cells       Date:  1996       Impact factor: 6.277

8.  CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.

Authors:  Evgeny Klyuchnikov; Jean El-Cheikh; Andreas Sputtek; Michael Lioznov; Boris Calmels; Sabine Furst; Christian Chabannon; Roberto Crocchiolo; Claude Lemarié; Catherine Faucher; Ulrike Bacher; Haefaa Alchalby; Thomas Stübig; Christine Wolschke; Francis Ayuk; Marie-Luise Reckhaus; Didier Blaise; Nicolaus Kröger
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-07       Impact factor: 5.742

9.  Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant.

Authors:  B Bolwell; B Pohlman; R Sobecks; S Andresen; S Brown; L Rybicki; V Wentling; M Kalaycio
Journal:  Bone Marrow Transplant       Date:  2004-02       Impact factor: 5.483

10.  Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.

Authors:  L R First; B R Smith; J Lipton; D G Nathan; R Parkman; J M Rappeport
Journal:  Blood       Date:  1985-02       Impact factor: 22.113
View more
  4 in total

1.  Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.

Authors:  Georgios E Christakopoulos; Todd E DeFor; Stefanie Hage; John E Wagner; Michael A Linden; Claudio Brunstein; Nelli Bejanyan; Michael R Verneris; Angela R Smith
Journal:  Transplant Cell Ther       Date:  2021-03-02

Review 2.  Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Leyre Bento; Mariana Canaro; José María Bastida; Antonia Sampol
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241

3.  Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature.

Authors:  Marta Bortolotti; Loredana Pettine; Anna Zaninoni; Giorgio Alberto Croci; Wilma Barcellini; Bruno Fattizzo
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-30

Review 4.  A Review of Romiplostim Mechanism of Action and Clinical Applicability.

Authors:  James B Bussel; Gerald Soff; Adriana Balduzzi; Nichola Cooper; Tatiana Lawrence; John W Semple
Journal:  Drug Des Devel Ther       Date:  2021-05-26       Impact factor: 4.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.